Key opinion leaders from Renovo Neural, Merck, Van Andel Research Institute, Ohio State University share their opinions on the benefits and pitfalls of using of animal models in translation research of neurodegenerative diseases

Speaker Interview with Kuldip Dave, PhD, Director of Research Programs, Michael J. Fox Foundation for Parkinson’s Research

An inside view on the strategy and work of The Michael J. Fox Foundation, and Dr. Dave’s work in directing the foundation’s Alpha-synuclein and Glucocerebrosidase portfolio.

Speaker Interview with Richard Wyse, Director of Research and Development, The Cure Parkinson’s Trust

A thought-provoking discussion about the current challenges and future opportunities in the development of efficacious therapeutics for Parkinson’s disease

 World CNS 2015 Presentations:

1) Pursuing Lysosomal enzymes as new drug targets for neurodegenerative and other common diseases

2) Novel Partnerships to Tackle CNS Diseases

Kiran Reddy, Senior Director of Corporate Strategy, Biogen Idec

World CNS 2014 Post Event Report

How to de-risk CNS drug development and improve the success rates of clinical trials.